Skip to main content
. 2019 Nov 1;7:261. doi: 10.3389/fcell.2019.00261

FIGURE 1.

FIGURE 1

(A) Sanger sequencing of patient-derived cells confirmed the presence of the SCN1B variants c.629T > C/p.L210P and c.637C > A/p.P213T. (B) An ECG of the patient before and after receiving ajmaline (1 mg/kg) presents typical BrS changes. (C) A family pedigree presents the affected patient and his affected son. Both persons have the same affected gene mutations in SCN1B as described in panel (A).